MiƱao, Aivie .
HRN: 05-17-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/24/2024
07/25/2024
IV
500mg
Q8 X 3 Doses
Post OP Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes